{
  "meta": {
    "title": "40_Biochemistry_Ini-Cet_2022",
    "url": "https://brainandscalpel.vercel.app/40-biochemistry-ini-cet-2022-1c48cb6e.html",
    "scrapedAt": "2025-11-30T12:57:58.767Z"
  },
  "questions": [
    {
      "text": "Which is the correct sequence of steps in the isolation of desirable protein using recombinant DNA technology?<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">Expression of protein and lysis of bacterial cell</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">Incorporation of genes into bacteria</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">SDS PAGE</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">Protein elution  <br /></span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">Hybridization</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 1, 3, 5, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 4, 3, 5"
        },
        {
          "id": 3,
          "text": "1, 5, 2, 4, 3"
        },
        {
          "id": 4,
          "text": "2, 4, 5, 3, 1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct sequence of isolation of desirable protein in recombinant DNA technology is <strong>2, 1, 3, 5, 4</strong>.</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">I)<strong> Incorporation of genes into bacteria</strong>: The gene needed to produce the desired proteins is to be incorporated into the bacteria. This is done using <strong>cloning vectors</strong> like bacterial plasmids, phages, or cosmids. The DNA of interest is ligated into the vector DNA and is called <strong>recombinant DNA</strong>. This vector is then inserted into a competent host cell (eg: E.coli bacteria) where it is replicated.</span></p>\n<p>II)<strong> Expression of protein </strong>and<strong> lysis of bacterial cell</strong>:  After <span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">incorpora</span>tion of recombinant DNA, bacteria<strong> express</strong> the <strong>inserted gene</strong> and produce the <strong>desired protein</strong> on a large scale along with other indigenous bacterial proteins. To<strong> release</strong> these <strong>proteins</strong> bacterial cell is<strong> lysed</strong>.</p>\n<p>III) <strong>SDS-PAGE</strong> (sodium dodecyl sulfate-polyacrylamide gel electrophoresis): It is the most widely used method for determining the purity of a protein.<strong> </strong>After the proteins are released, to <strong>separate </strong>the <strong>desirable protein</strong>, we subject it to SDS-PAGE. It separates proteins based on <strong>molecular weight</strong>.</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\">IV) <strong>Hybridization and blotting</strong>: It is done to <strong>confirm</strong> that the <strong>isolated protein</strong> is the <strong>desired protein</strong>. It is done using <strong>western blotting</strong> techniques on nitrocellulose paper.</span></p>\n<p>V)<strong><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;We can use these options\\n1. Lysis of bacterial cell\\n2. Incorporation of gene into bacteria\\n3. SDS page\\n4. Hybridisation\\n5. Protein expression/ elution (whichever reference is available)&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:771,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16773836},&quot;11&quot;:4,&quot;12&quot;:0}\"> Protein e</span>lution </strong>- extraction of the produced protein.</p>\n<p> </p>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The practical </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>applications </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">of<strong> </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>recombinant DNA technolog</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">y include:</span></p>\n<ul>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Gene mapping</strong> using techniques such as fluorescence in situ hybridization </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(FISH).</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Producing <strong>proteins</strong> such as:</span>\n<ul>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Interferons, <strong>tPA </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(tissue </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">plasminogen activator)</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Insulin</strong>, growth hormone</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Hepatitis B vaccine</span></li>\n</ul>\n</li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Molecular analysis</strong> of disease, to detect gene variations and mutations.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Restriction Fragment Length polymorphism (<strong>RFLP</strong>) and single nucleotide polymorphism (<strong>SNP</strong>)</span></li>\n<li><strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Microsatellite DNA polymorphisms</span></strong></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Gene therapy</strong> and <strong>bone</strong> <strong>marrow</strong> transplantation</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5227",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following techniques is used to detect DNA-protein interaction?",
      "choices": [
        {
          "id": 1,
          "text": "DNA footprinting"
        },
        {
          "id": 2,
          "text": "DNA fingerprinting"
        },
        {
          "id": 3,
          "text": "ELISA"
        },
        {
          "id": 4,
          "text": "Northern blotting"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The technique used to detect DNA-protein interaction is <strong>DNA footprinting</strong>.</p>\n<p>The parts of <strong>DNA</strong> that are <strong>protein-bound </strong>(Eg: RNA polymerase bound to the promoter region of DNA) are resistant to digestion by nuclease enzymes. Since the nucleases are unable to cleave the protein-bound regions of DNA, when the cleaved DNA fragments are run on polyacrylamide gel electrophoresis, there are <strong>missing bands</strong> indicating, <strong>protected sites</strong> of protein-bound DNA. These missing areas represent the <strong>footprint</strong> of the protected <strong>DNA-protein complexes</strong>. Hence DNA footprinting technique helps to identify the<strong> specific binding site</strong> of protein on a DNA sequence.</p>\n<p>The image below illustrates the DNA footprinting technique.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/78b95f0916ed4a0eaa1dfe8d14aba37ax1280x2025.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B: <strong>DNA fingerprinting</strong> uses RFLPs (restriction fragment length polymorphism) or repeat sequence DNA to identify a person's <strong>unique pattern </strong>of<strong> DNA</strong>. Polymorphisms are inherited differences found among individuals. with this technique, individuals can be differentiated by variations in their DNA sequence, using restriction endonucleases followed by gel electrophoresis, to visualize RFLPs.<strong> </strong>DNA fingerprinting is used for forensic analysis of crime scenes, and for paternity testing. </p>\n<p>Option C: <strong>ELISA</strong> uses antibodies linked to certain enzymes to <strong>detect</strong> certain<strong> antigens</strong> present in the sample.</p>\n<p>Option D: <strong>Northern blotting </strong>technique can be used to <strong>detect</strong> <strong>RNA</strong>. Here, the mixture of <strong>mRNA</strong> molecules is separated by electrophoresis and then transferred to a nitrocellulose membrane and hybridized with radiolabeled probes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4948",
      "difficulty": "medium"
    },
    {
      "text": "A patient was diagnosed with Ewing sarcoma with EWSR1 gene mutation. The technique shown in the image was performed to confirm the diagnosis. Identify the technique shown in the image.",
      "choices": [
        {
          "id": 1,
          "text": "Fluorescent in situ hybridisation"
        },
        {
          "id": 2,
          "text": "Karyotyping"
        },
        {
          "id": 3,
          "text": "Immunohistochemistry"
        },
        {
          "id": 4,
          "text": "Sanger's technique"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The technique shown in the image is <strong>FISH </strong>demonstrating a positive <strong>EWSR1 gene rearrangement</strong>, characteristic of <strong>Ewing sarcoma</strong>. The <strong>fused </strong>region denoted by<strong> Yellow </strong>corresponds to a <strong>normal intact gene</strong>, while a<strong> split signal </strong>pattern showing separate <strong>red </strong>and<strong> green signals</strong> is indicative of<strong> </strong>EWSR1 gene rearrangement.</p>\n<p><strong class=\"ng-binding\">Fluorescent In Situ Hybridisation (FISH) </strong>is a simple technique for the detection of specific genetic information on morphologically intact tissue using fluorescent probes. FISH can be performed on prenatal samples, peripheral blood cells, touch preparations from cancer biopsies, and even fixed archival tissue sections. It is used to detect</p>\n<ul>\n<li><strong>numeric abnormalities</strong> of chromosomes (aneuploidy)</li>\n<li>subtle <strong>microdeletions </strong>and<strong> rearrangements</strong>.</li>\n<li>complex <strong>translocations</strong> that are not demonstrable by routine karyotyping</li>\n<li><strong>gene amplification</strong> (e.g., HER2 in breast cancer or NMYC amplification in neuroblastomas)</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Karyotyping</strong> is the process by which chromosomes are isolated, stained, and examined to find chromosomal anomalies. It is used in prenatal diagnosis, investigation of repeat pregnancy loss, investigation of children and adults suspected of having a chromosomal disorder, and subtyping of lymphomas and leukemias for the purpose of exact diagnosis, giving a prognosis, and treatment.</p>\n<p>Option C: <strong>IHC</strong> (Immunohistochemistry) is a staining method for histopathological specimens. It helps in the diagnosis and classification of tumors based on their distinct protein expression patterns. Eg: The expression of estrogen receptor (ER), progesterone receptor (PR), and HER2/neu in breast cancer cells is mainly assessed by immunohistochemistry.</p>\n<p>Option D: <strong>Sanger's technique</strong>:<strong> </strong>This was the first technique used to determine the <strong>sequence of proteins. </strong>The first protein to be sequenced by this method was <strong>insulin. </strong>Sanger’s reagent is<strong> </strong>1- Flouro 2,4 Dinitro benzene.<strong> </strong>Only <strong>dipeptides </strong>and <strong>tripeptides </strong>can be sequenced by this method.</p><hr><h3>Related Pearl: Fluorescent In Situ Hybridisation (FISH)</h3><p>It is a simple technique for the detection of specific genetic information on a morphologically intact tissue using fluorescent probes.</p>\n<p>The fluorescent probes are added to cells usually arrested in the metaphase stage of cell division (when every chromosome is separately).</p>\n<p><strong>Types of FISH</strong>:</p>\n<p>1) <strong>Chromosomal painting</strong>: Each chromosome is identified by using a different colour of the fluorescent probe, however, each chromosome does not have a unique colour. Since the fluorescent dyes are limited.</p>\n<p>2) <strong>Multicolour FISH</strong>: 23 distinct fluorescent colours made by mixing 5 fluorophores. Thus each chromosome is identified by a unique colour. It is also known as spectral karyotyping (SKY). It offers various advantages such as</p>\n<ul>\n<li>Detects structural and numeric abnormalities in chromosomes.</li>\n<li>Detects gene amplification and subtle microdeletions</li>\n<li>Maps a newly isolated gene to its correct chromosomal loci</li>\n</ul>\n<p>However, this process requires prior knowledge of the genes and chromosomes.</p>\n<p>3) <strong>Interphase FISH</strong>: It is a rapid procedure of FISH, wherein growing cells are not needed. It is used in prenatal diagnosis and in tumour diagnosis.</p><p>The image shown is of a Multicolor FISH also known as Spectral karyotyping with a unique colour to each chromosome pair.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d4f735c91d6a4ab68baac0550ecded82.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5026",
      "difficulty": "easy"
    },
    {
      "text": "In a patient with maple syrup urine disease, all of the following amino acids should be restricted in diet except?",
      "choices": [
        {
          "id": 1,
          "text": "Methionine"
        },
        {
          "id": 2,
          "text": "Valine"
        },
        {
          "id": 3,
          "text": "Leucine"
        },
        {
          "id": 4,
          "text": "Isoleucine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In maple syrup urine disease (<strong>MSUD</strong>), only <strong>branched-chain amino acids</strong> are restricted, hence, methionine does not need any restriction in diet.</p>\n<p>Branched-chain amino acids are:</p>\n<ul>\n<li><strong>Leucine</strong>&nbsp;(L)</li>\n<li><strong>Isoleucine&nbsp;</strong>(I)</li>\n<li><strong>Valine&nbsp;</strong>(V)</li>\n</ul>\n<p>MSUD is an <strong>autosomal recessive</strong> disorder in which there is a partial or complete deficiency of&nbsp;<strong>branched-chain ketoacid dehydrogenase</strong>&nbsp;complex (BCKD). This impairs the metabolism of branched-chain amino acids.&nbsp;These amino acids, particularly leucine and their metabolite accumulate in the blood, causing toxic effects on the brain.&nbsp;Features include feeding problems, vomiting, ketosis, and a characteristic&nbsp;<strong>burnt sugar</strong>&nbsp;<strong>odor&nbsp;</strong>/<strong>maple syrup-like odor</strong> found in&nbsp;<strong>urine</strong>,&nbsp;sweat, and&nbsp;cerumen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b61ae3b601a4b78b29862ed1e28df01x1279x1324.JPEG\" alt=\"Explanation Image\"><p>Laboratory investigations will show increased&nbsp;<strong>levels&nbsp;</strong>of&nbsp;<strong>branched-chain amino acids</strong>&nbsp;in the plasma and urine. <strong>Leucine</strong> levels are usually higher than isoleucine, and valine.</p>\n<p>Treatment involves <strong>restricted intake</strong> of <strong>branched-chain amino acids</strong> using commercially available formulas and judicious supplementation of isoleucine and valine. Very high levels of leucine are removed by&nbsp;<strong>hemodialysis.</strong></p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4951",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about the human genome project is false?",
      "choices": [
        {
          "id": 1,
          "text": "Total  20,500 genes were identified"
        },
        {
          "id": 2,
          "text": "The project spanned over 13 years"
        },
        {
          "id": 3,
          "text": "It required international collaboration"
        },
        {
          "id": 4,
          "text": "Next generation sequencing was used"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The human genome project <strong>did not use next-generation sequencing</strong>.</p>\n<p>The Human Genome Project (HGP) was an <strong>international</strong>,<strong> collaborative</strong> research program, which involved agencies such as UNESCO, HUGO, the National Institute of Health/Department of Energy (USA), the Medical Research Council (UK), Genethon (France), and the European Union. The primary goal of the&nbsp;Human Genome Project&nbsp;was to determine the&nbsp;<strong>sequence</strong> of all&nbsp;<strong>nucleotide base pairs</strong>,&nbsp;that make up human DNA and to create<strong>&nbsp;</strong>a single linear <strong>map</strong>&nbsp;of&nbsp;<strong>all genes</strong>&nbsp;from the human genome. The project was active from&nbsp;<strong>1990 </strong>to&nbsp;<strong>2003</strong>, taking around <strong>13 years&nbsp;</strong>to complete.&nbsp;A total of <strong>20500 genes</strong> were identified and mapped. Scientists used various methods of&nbsp;<strong>first-generation sequencing technologies</strong> including <strong>sanger's technique</strong>, SGS technique, etc.&nbsp;The HGP has produced a curated and accurate <strong>reference sequence</strong> for the majority of human chromosomes. The reference sequence has provided the foundation for the use of second-generation sequencing technologies such as array techniques.</p>\n<p><strong>Next-generation sequencing (NGS) </strong>is a new technology used for<strong> sequencing </strong>DNA and RNA and mutation detection. NGS can sequence the genome faster and in a shorter period of time than first-generation sequencing technologies.&nbsp;NGS allows for the detection of a spectrum of mutations, including single nucleotide substitutions, small insertions and deletions, large genomic duplications and deletions, and rare variations. Next-generation DNA sequencing technologies include</p>\n<ul>\n<li>Illumina sequencing</li>\n<li>Roche 454 sequencing</li>\n<li>Ion torrent: Proton/PGM sequencing</li>\n<li>SOLID sequencing.</li>\n</ul><p><span data-preserver-spaces=\"true\"><strong>Nobel prize 2022 in physiology or Medicine</strong> was awarded to <strong>Dr</strong>&nbsp;</span><strong><span data-preserver-spaces=\"true\">Svante P&auml;&auml;bo, who&nbsp;</span></strong><span data-preserver-spaces=\"true\">found that gene transfer had occurred from the extinct hominins (Neanderthal &amp; Denisova, extinct relatives of present-day humans) to Humans with the help of genome sequencing. This ancient flow of genes to present-day humans has physiological relevance today, for example affecting how our immune system reacts to infections.</span></p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4982",
      "difficulty": "medium"
    },
    {
      "text": "Banding technique used for dicentric chromosomes is:",
      "choices": [
        {
          "id": 1,
          "text": "G banding"
        },
        {
          "id": 2,
          "text": "C banding"
        },
        {
          "id": 3,
          "text": "NOR"
        },
        {
          "id": 4,
          "text": "R banding"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The banding technique used for dicentric chromosomes is <strong>C banding</strong>.</p>\n<p>Heterochromatin includes non-coding regions of DNA, such as <strong>centromeric regions</strong>. The staining of these constitutive heterochromatins, is done by<strong>&nbsp;C-banding </strong>using silver salt staining. A <strong>dicentric</strong> chromosome having <strong>two centromeres</strong> can hence be identified by C banding.</p>\n<p>Various techniques are used in karyotyping to study chromosomes. Staining with various compounds produces various results and helps us to understand the chromosomes better.</p>\n<p>Common techniques&nbsp;used are:</p>\n<ul>\n<li><strong>Q banding -&nbsp;</strong>Fluorescence staining with quinacrine mustard.</li>\n<li><strong>G banding -&nbsp;</strong>Giemsa staining after&nbsp;partial denaturation of chromatin. It&nbsp;is the most common technique used in cytogenetics to produce a visible karyotype by staining condensed chromosomes.</li>\n<li><strong>R banding -&nbsp;</strong>Reverse&nbsp;Giemsa staining. In this, the light and dark areas are reversed.</li>\n<li><strong>C banding -&nbsp;</strong>staining of heterochromatin with silver salts.</li>\n<li><strong>T banding -&nbsp;</strong>staining the telomeres of chromosomes.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5036",
      "difficulty": "medium"
    },
    {
      "text": "Affinity maturation of antibodies is because of?",
      "choices": [
        {
          "id": 1,
          "text": "Somatic hypermutation"
        },
        {
          "id": 2,
          "text": "Differential mRNA processing"
        },
        {
          "id": 3,
          "text": "CD40"
        },
        {
          "id": 4,
          "text": "Gene rearrangements"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Affinity maturation of antibodies is because of <strong>somatic hypermutation</strong>.</p>\n<p><strong>Affinity maturation&nbsp;</strong>is the process by which&nbsp;antibodies gain increased&nbsp;affinity,&nbsp;avidity,&nbsp;and&nbsp;anti-pathogen activity.&nbsp;It is a&nbsp;result of <strong>somatic hypermutation</strong>&nbsp;of immunoglobulin genes in B cells, coupled with selection for antigen binding.</p>\n<p><strong>Somatic hypermutation</strong>&nbsp;is a cellular response by which the immune system adapts to the new foreign elements that confront it. They do so by adding nucleotides in V gene regions of heavy and light chains, resulting in a<strong> better fit</strong> of antigen with the antibodies. This hence <strong>increases</strong> the <strong>affinity</strong> of antibodies to antigens. Due to this, the subset of plasma cells with these improved hypervariable regions are more strongly<br />selected by the antigen and therefore constitute a larger part of the population of antibody-producing cells. This process is called <strong>affinity maturation</strong>.</p>\n<p>This process occurs in the&nbsp;<strong>germinal centers</strong>&nbsp;and proceeds for weeks after acute infection or vaccination, or for many cycles during chronic infection. The resulting antibodies can be&nbsp;<strong>highly mutated</strong>&nbsp;from their germline-encoded counterparts, with an increase in several orders of magnitude in affinity for antigen compared to the corresponding na&iuml;ve B cell receptors (BCRs).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5001",
      "difficulty": "medium"
    },
    {
      "text": "Best method for detection of mutations with low allele frequency is",
      "choices": [
        {
          "id": 1,
          "text": "Droplet digital PCR"
        },
        {
          "id": 2,
          "text": "FISH"
        },
        {
          "id": 3,
          "text": "Nested PCR"
        },
        {
          "id": 4,
          "text": "Sanger Sequencing"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Best method for detection of mutation with low allele frequency is <strong>Droplet digital PCR</strong> (ddPCR)</p>\n<p>It is an advanced and <strong>more precise</strong> type of <strong>quantitative PCR </strong>which gives more consistent and reproducible results.<strong> </strong>It can <strong>accurately quantify</strong> the target nucleic acid sequence within a sample. It is useful for determining somatic mutation with low allele frequency. Mutant alleles of frequency as low as 0.25% can also be detected using this technique. </p>\n<p><strong>Polymerase chain reaction (PCR) </strong>is a rapid automated method for the amplification of specific DNA sequences (or genes). <strong>Reverse transcriptase PCR- </strong>The enzyme reverse transcriptase (RT) is used to synthesize a complimentary copy of DNA (cDNA) from RNA and this cDNA is then used as a template for PCR.</p>\n<p><strong>Other special PCR types:</strong></p>\n<p><strong>Nested PCR-</strong> It involves the sequential use of <strong>two primer sets</strong>. The first primer set is used for amplification and the target sequence for the second primer is present only on the amplicon with the target sequence. Nested PCR is intended to reduce non-specific binding due to the amplification of unexpected primer binding sites.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/24a6c67a71c147d48c2461e68e660e4ex1120x1354.PNG\" alt=\"Explanation Image\"><p><strong>Multiplex PCR-</strong> Multiple primers are used to amplify several DNA sequences simultaneously. As this process targets multiple genes at once, a single test run gives additional information that would otherwise require several times the reagents and technician time to perform. </p>\n<p>The <strong>Sanger sequencing</strong> technique is used for <strong>DNA sequencing</strong>. It is based on controlled termination of synthesis of DNA by using chain terminating agents like dideoxynucleotides.</p>\n<p><strong class=\"ng-binding\">Fluorescent In Situ Hybridisation (FISH) </strong>is a simple technique for the detection of specific genetic information on morphologically intact tissue using fluorescent probes. FISH can be performed on prenatal samples, peripheral blood cells, touch preparations from cancer biopsies, and even fixed archival tissue sections.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4999",
      "difficulty": "hard"
    },
    {
      "text": "In Sanger sequencing, ddNTP is used because:",
      "choices": [
        {
          "id": 1,
          "text": "It is used to increase DNA polymerase activity"
        },
        {
          "id": 2,
          "text": "It can be made fluorescent"
        },
        {
          "id": 3,
          "text": "They exhibit higher affinity for DNA polymerases"
        },
        {
          "id": 4,
          "text": "It doesn't allow further elongation of DNA"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In <strong>Sanger sequencing</strong>, <span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\"><strong>dideoxynucleotides triphosphates&nbsp;</strong></span></span>(ddNTP) are used because it <strong>doesn't allow further elongation of DNA</strong>.</p>\n<p>The Sanger method is used for <strong>DNA sequencing</strong>. This method uses the mechanism of synthesis of DNA by <strong>DNA polymerases</strong>. In the process of synthesis of DNA, the 3'-hydroxyl group of primer reacts with an incoming dNTP to form a new phosphodiester bond. This reaction is catalyzed by DNA polymerase.</p>\n<p>In the Sanger sequencing method, ddNTP is used because it halts the DNA synthesis. ddNTPs can bind to the template strand but lack the 3'-hydroxyl group which is required to add the next nucleotide. The products of this reaction are a mixture of DNA strands of varying lengths. This mixture is then separated using polyacrylamide gel electrophoresis and autoradiography. This produces a pattern of bands from which the DNA sequence can be read.</p>\n<p>The image given below shows the steps involved in Sanger's method.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/92241a874eba422bb066650b71f4e59ex1024x1024.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Sanger&rsquo;s technique</strong> was the first technique used to determine the&nbsp;sequence of proteins.<strong>&nbsp;</strong>The first protein to be sequenced by this method was&nbsp;<strong>insulin.&nbsp;</strong>Sanger&rsquo;s reagent is<strong>&nbsp;1- fluoro 2,4 dinitro benzene.&nbsp;</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4990",
      "difficulty": "medium"
    },
    {
      "text": "Misincorporation of uracil into DNA is seen in deficiency of:",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B12"
        },
        {
          "id": 2,
          "text": "Folate"
        },
        {
          "id": 3,
          "text": "Vitamin B6"
        },
        {
          "id": 4,
          "text": "Vitamin E"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Misincorporation of uracil into DNA is seen in the deficiency of <strong>folate</strong>.&nbsp;</p>\n<p>Folate deficiency leads to <strong>decreased&nbsp;thymidylate&nbsp;synthesis</strong> from deoxyuridylate due to deficient methylation of&nbsp;deoxyuridine monophosphate (dUMP) to thymidine monophosphate (TMP).&nbsp;The methylation of dUMP to TMP is catalyzed by <strong>thymidylate synthase</strong> and <strong>requires&nbsp;</strong>tetrahydrofolate&nbsp;(<strong>THFA</strong>) as a methyl group donor. This <strong>decreased TMP synthesis</strong> can<strong>&nbsp;</strong>result in an imbalance of deoxyribonucleotides and hence leading to <strong>excessive uracil misincorporation</strong> into DNA during replication and repair.</p>\n<p>Folic acid (vitamin <strong>B9</strong>) is a water-soluble vitamin, and its active form is tetrahydrofolate (<strong>THFA</strong>). It acts as a carrier of&nbsp;<strong>one-carbon groups.&nbsp;</strong>Tetrahydrofolate receives&nbsp;one-carbon fragments&nbsp;from&nbsp;donors&nbsp;such as serine, glycine, and histidine and transfers them to intermediates in the synthesis of amino acids, <strong>purines</strong>, and <strong>pyrimidines</strong>.</p>\n<div class=\"page\" title=\"Page 416\">&nbsp;</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ee4e74c9abc84ce4a1745d163afebbf3x1280x1276.JPEG\" alt=\"Explanation Image\"><p>Folate deficiency results in:</p>\n<ul>\n<li>Megaloblastic anemia&nbsp;</li>\n<li>Homocystenemia</li>\n<li>Neural tube defects&nbsp;(spina bifida, Anencephaly) in the fetus.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4980",
      "difficulty": "medium"
    },
    {
      "text": "Deamination of methylated cytosine forms which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Uracil"
        },
        {
          "id": 2,
          "text": "Cytosine"
        },
        {
          "id": 3,
          "text": "Guanine"
        },
        {
          "id": 4,
          "text": "Thymine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Deamination of methylated cytosine forms <strong>thymine</strong>.</p>\n<p>Deamination is the<strong> removal </strong>of an<strong> amino group</strong>(NH2) from a chemical compound. Enzymes that catalyze this reaction are called <strong>deaminases</strong>. Deamination of 5-methylcytosine forms thymine. </p>\n<p>Other significant deaminations are given below:</p>\n<ul>\n<li>Deamination of <strong>adenosine</strong> forms <strong>inosine</strong>. This is a metabolic step involved in uric acid formation by purine catabolism. It is mediated by the enzyme <strong>adenosine deaminase</strong> (<strong>ADA</strong>). ADA deficiency leads to sparse or defective T cells and B cells and patients suffer from <strong>Severe combined immunodeficiency </strong>(<strong>SCID</strong>).</li>\n<li>Deamination of <strong>cytosine</strong> leads to <strong>uracil </strong>formation - The production of apolipoprotein B-48 (apoB-48) in the intestine is the result of <strong>RNA editing</strong> in the intestine. This involves post-transcriptional<strong> deamination</strong> of cytosine to uracil<strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> </span></strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">by enzyme</span><strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">cytidine deaminase</span></strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">. This</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">converts sense codon (</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">CAA) </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">in the mRNA to nonsense codon (</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">UAA)at a single specific site. This edited mRNA translates to apoB-48.</span></li>\n<li>Deamination of<strong> guanine</strong> forms <strong>xanthine</strong>. This is a metabolic step involved in uric acid formation by purine catabolism.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4986",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following types of inhibition is depicted in the given Lineweaver-Burk plot?",
      "choices": [
        {
          "id": 1,
          "text": "Competitive inhibition"
        },
        {
          "id": 2,
          "text": "Non-competitive inhibition"
        },
        {
          "id": 3,
          "text": "Uncompetitive inhibition"
        },
        {
          "id": 4,
          "text": "Suicidal inhibition"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given graph shows <strong>competitive inhibition</strong>,<strong>&nbsp;</strong>in which the value of V<sub>max</sub> remains constant and the K<sub>m</sub> value increases.</p>\n<ul>\n<li><strong>K<sub>m </sub></strong>is the&nbsp;substrate concentration at which velocity is half maximum.</li>\n<li><strong>V<sub>max</sub></strong>&nbsp;is the maximum velocity of a reaction.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Inhibition</strong></td>\n<td><strong>K<sub>m</sub></strong></td>\n<td><strong>V<sub>max</sub></strong></td>\n</tr>\n<tr>\n<td>Competitive</td>\n<td>Increases</td>\n<td>Same</td>\n</tr>\n<tr>\n<td>Non Competitive</td>\n<td>Same</td>\n<td>Decreases</td>\n</tr>\n<tr>\n<td>Uncompetitive</td>\n<td>Decreases</td>\n<td>Decreases</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Competitive inhibition&nbsp;</strong>is when the inhibitor binds <strong>reversibly</strong> to the substrate-binding site and competes with the substrate for the active enzyme-binding site. This effect of competitive inhibition can be overcome <strong>by increasing</strong> the <strong>substrate concentration</strong> by which maximum velocity can still be achieved. Therefore,&nbsp;<strong>V<sub>max</sub></strong>&nbsp;is&nbsp;<strong>unaltered</strong>&nbsp;in this type of inhibition. However, the concentration of the substrate required to achieve half of the maximum velocity is increased. Therefore,&nbsp;<strong>K<sub>m</sub></strong>&nbsp;is&nbsp;<strong>increased</strong>&nbsp;in this condition.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The graph shows the changes in V<sub>max</sub>&nbsp;and K<sub>m</sub> in competitive inhibition.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ffd327a25fb045959c699d4ffb05e602x1280x2235.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B:<strong> Non-competitive inhibition&nbsp;</strong>is by binding inhibitors&nbsp;to enzymes in&nbsp;<strong>locations remote</strong>&nbsp;from the active site. <strong>Increasing</strong> the<strong> concentration</strong> of the substrate <strong>does not overcome</strong> non-competitive inhibition. Thus, noncompetitive inhibitors&nbsp;<strong>decrease the V<sub>max</sub>&nbsp;of the reaction</strong>. They do not interfere with the binding of the substrate to the enzyme. Thus, the enzyme shows the<strong>&nbsp;same K<sub>m</sub></strong>&nbsp;in the presence or absence of noncompetitive inhibitors.</p>\n<div class=\"ng-scope\">The graph shows the changes in V<sub>max</sub>&nbsp;and K<sub>m</sub> in non-competitive inhibition.</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7810bbf695664063b9db9500778f3296x1280x2317.JPEG\" alt=\"Explanation Image\"><p>Option C: In<strong>&nbsp;uncompetitive inhibition,&nbsp;</strong>inhibitors bind with the enzyme-substrate&nbsp;<strong>intermediate complex</strong>, and inhibit it. This leads to decrease in both Vmax and Km. An example is the inhibition of <strong>placental</strong> alkaline phosphate (<strong>ALP</strong>) by <strong>phenylalanine</strong>.&nbsp;</p>\n<p>Option D:&nbsp;<strong>Suicidal inhibition&nbsp;</strong>is a special type of&nbsp;<strong>irreversible inhibition</strong>. The inhibitor here makes use of the enzyme's own reaction mechanism to inactivate it and is hence known as <strong>mechanism-based inactivation</strong>. An example is <strong>allopurinol</strong>, which is oxidized by xanthine oxidase to alloxanthine. Alloxanthine in turn is a more potent inhibitor of xanthine oxidase.&nbsp;</p><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Some Examples of Suicidal Inhibitors</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Suicidal Inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Enzyme</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Allopurinol</p>\n</td>\n<td>\n<p>Xanthine oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Cyclooxygenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5-Flurouracil</p>\n</td>\n<td>\n<p>Thymidylate synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Penicillin</p>\n</td>\n<td>\n<p>Transpeptidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DFMO</p>\n</td>\n<td>\n<p>Ornithine Decarboxylase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c6dbf0858b25472e893e3facd56a8731.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5030",
      "difficulty": "easy"
    },
    {
      "text": "Glycogen phosphorylase is activated by:",
      "choices": [
        {
          "id": 1,
          "text": "Calcium"
        },
        {
          "id": 2,
          "text": "Glucose-6-phosphate"
        },
        {
          "id": 3,
          "text": "Insulin"
        },
        {
          "id": 4,
          "text": "Protein phosphatase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 178\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Glycogen phosphorylase is activated by <strong>calcium </strong>in the muscle<strong>.</strong></p>\n<p>Glycogen phosphorylase&nbsp;is the <strong>rate-limiting</strong> enzyme of&nbsp;<strong>glycogenolysis</strong>&nbsp;and is decreased in the fed state.</p>\n<p>In the muscle, the<strong> increased&nbsp;cytosolic calcium</strong> ion concentration initiates both&nbsp;<strong>contraction</strong> and <strong>glycogenolysis</strong>.&nbsp;Muscle phosphorylase kinase has four different subunits, &alpha;, &beta;, &gamma;, and &delta;. The &alpha; and &beta; subunits are phosphorylated by cAMP-dependent protein kinase. The <strong>&delta; subunit</strong> is identical to the calcium-binding protein calmodulin and binds four calcium ions.<strong>&nbsp;</strong>Calcium <strong>coordinates</strong> the <strong>activation</strong> of Glycogen Phosphorylase with the&nbsp;<strong>contraction</strong> of the muscle.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Glycogen phosphorylase catalyzes the cleavage of&nbsp;<strong>&alpha;1 &rarr; 4 linkages</strong>&nbsp;of glycogen to&nbsp;single units of <strong>glucose 1-phosphate</strong>. It&nbsp;uses&nbsp;<strong>pyridoxal phosphate</strong>&nbsp;as the coenzyme. Different isoenzymes of glycogen phosphorylase are seen in the liver, muscles, and brain.</p>\n<p>Other options:</p>\n<p>Option B: During glycogenolysis, <strong>glucose 6-phosphate</strong> allosterically <strong>inhibits</strong> glycogen phosphorylase.&nbsp;</p>\n<div class=\"page\" title=\"Page 254\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 254\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option C: <strong>Insulin</strong>&nbsp;entirely&nbsp;<strong>suppresses</strong> glycogenolysis in the skeletal muscle and liver.</p>\n<div class=\"page\" title=\"Page 254\">Option D: In glycogenolysis <strong>protein phosphatase</strong> is <strong>inactivated</strong> by inhibitor proteins in response to cAMP, to maintain the glycogen phosphorylase in an active state.</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Glycogenolysis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d899de2c563b46f3a4712e021cba77d7x1280x1333.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7225",
      "difficulty": "medium"
    },
    {
      "text": "Mutation of the gene of cystic fibrosis occurs with:",
      "choices": [
        {
          "id": 1,
          "text": "Tryptophan at 708 position, chloride channel"
        },
        {
          "id": 2,
          "text": "Phenylalanine at 708 position, calcium channel"
        },
        {
          "id": 3,
          "text": "Phenylalanine at 508 position, chloride channel"
        },
        {
          "id": 4,
          "text": "Tryptophan at 508 position, calcium channel"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The mutant gene of cystic fibrosis (CF gene) produces a mutant <strong>CFTR protein</strong> with the<strong> deletion of a phenylalanine residue at 508</strong>&nbsp;(F508del), characterised by impaired&nbsp;<strong>chloride&nbsp;</strong>secretion.</p>\n<p><strong>Cystic fibrosis</strong> is a condition with an&nbsp;<strong>autosomal recessive</strong> mode of inheritance.&nbsp;It results due to a defective mutation in the gene encoding for cystic fibrosis <strong>transmembrane conductance regulator</strong> (CF gene). It plays an important role in <strong>mucociliary transport</strong> along the respiratory mucosa. It also helps to regulate the amount of exocrine gland secretion.</p>\n<p>The defect in the ion channel results in the production of <strong>hyper-viscous</strong>, <strong>adherent secretions</strong> which can obstruct the airways. Organisms such as <strong><em>Pseudomonas aeruginosa</em></strong> and <em>Staphylococcus aureus</em> can grow in the sputum. The <strong>exocrine</strong> <strong>pancreas</strong> can undergo fibrotic scarring, cyst formation, and acinar tissue loss. The viscid secretions can lead to pancreatic duct obstruction. The flow of <strong>digestive enzymes</strong> to the duodenum is hence impaired.</p>\n<p>Symptoms include sinusitis,<strong> steatorrhea</strong>, and abdominal pain. <strong>Distal intestinal obstruction</strong> is a complication due to difficulty in excreting intestinal contents. In neonates, it can present as <strong>meconium ileus</strong>.&nbsp;</p>\n<p>Detection of high levels of <strong>trypsinogen</strong> is used in <strong>newborn</strong> screening. <strong>Chloride level &gt;60mEq/L</strong> in the <strong>sweat</strong> of affected patients is diagnostic. <strong>Hyponatremic hypochloremic alkalosis</strong>&nbsp;is&nbsp;seen.</p>\n<p>Postural drainage, <strong>short-term antibiotics</strong>, and inhaled bronchodilators can be used for medical management. The definitive treatment is <strong>lung transplantation</strong>.</p>\n<p>The image below shows the features of the disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e555b9bfbd3a4256bb9e9a1e09e41011x480x342.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7243",
      "difficulty": "medium"
    },
    {
      "text": "A baby is brought to the OPD with complaints of lethargy and poor feeding. On examination, it is noted that the urine had a smell of burnt sugar. A defect in which of the following enzymes causes this disease?",
      "choices": [
        {
          "id": 1,
          "text": "Branched-chain ketoacid dehydrogenase"
        },
        {
          "id": 2,
          "text": "Branched-chain amino acid dehydrogenase"
        },
        {
          "id": 3,
          "text": "Branched-chain ketoacid oxidase"
        },
        {
          "id": 4,
          "text": "Branched-chain amino acid oxidase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The diagnosis, in this case, is that of <strong>maple syrup urine disease&nbsp;</strong>(MSUD).&nbsp;This disease occurs due to a defect of the enzyme&nbsp;<strong>branched-chain keto acid dehydrogenase.</strong></p>\n<p class=\"p1\">&nbsp;MSUD is an <strong>autosomal recessive</strong> disorder that occurs due to a <strong>deficiency of branched-chain ketoacid dehydrogenase complex</strong>. This impairs the metabolism of branched-chain amino acids <strong>valine, leucine, isoleucine, </strong>and<strong> alloisoleucine</strong>. These amino acids, particularly leucine and its metabolite accumulate in the blood, causing toxic effects on the brain.</p>\n<p class=\"p1\">The affected child develops poor feeding and vomiting a few days after birth. There is a period of hypertonicity with a period of flaccidity in between. These appear as repetitive <strong>boxing</strong> and <strong>bicycling movements</strong>. The babies may also have <strong>hypoglycemia</strong>, but this is <strong>not corrected by</strong> the administration of <strong>glucose</strong>. The <strong>urine, sweat, and cerumen</strong> of the baby have a <strong>sweetish maple syrup-like odor.</strong></p>\n<p class=\"p1\">Laboratory investigations will show <strong>increased</strong> levels of <strong>branched-chain amino acids</strong> in the plasma and urine. Leucine levels are usually higher than isoleucine, valine, and alloisoleucine. Since the patient excretes ketone bodies in the urine, the urine will be positive for the <strong>dinitrophenylhydrazine test</strong>.</p>\n<p class=\"p1\">Treatment involves controlled intake of branched-chain amino acids using commercially available formulas and judicious supplementation of isoleucine and valine. Very high levels of leucine are removed by <strong>hemodialysis</strong>.</p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3751",
      "difficulty": "easy"
    },
    {
      "text": "All are true about the hexose monophosphate shunt, except:",
      "choices": [
        {
          "id": 1,
          "text": "Source of ribose-5-phosphate"
        },
        {
          "id": 2,
          "text": "Source of Acetyl CoA"
        },
        {
          "id": 3,
          "text": "Source of NADPH"
        },
        {
          "id": 4,
          "text": "Utilises ribose"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>hexose monophosphate</strong> (HMP) shunt<strong> produces ribose</strong>&nbsp;and <strong>does not utilize it</strong>.&nbsp;</p>\n<p>The pentose phosphate pathway, also known as the HMP shunt pathway, is an alternative route for the <strong>metabolism of glucose</strong>.&nbsp;It contributes in two major ways:</p>\n<ul>\n<li><strong>Formation of NADPH&nbsp;</strong>for the synthesis of fatty acids and steroids and maintenance of reduced glutathione for antioxidant activity.</li>\n<li><strong>Formation of ribose&nbsp;</strong>for the synthesis of nucleic acid and nucleotides</li>\n</ul>\n<p>The enzymes for this pathway are found in the cytosol. There are two phases:</p>\n<ol>\n<li><strong>Irreversible oxidative phase</strong>: Glucose-6-phosphate is dehydrogenated and decarboxylated to form ribulose-5-phosphate which in turn gets converted to <strong>ribose-5-phosphate</strong>.</li>\n<li><strong>Reversible non-oxidative phase</strong>: Ribulose-5-phosphate is converted back to glucose-6-phosphate.&nbsp; &nbsp;</li>\n</ol>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/85f8c4aa0d0349c3b79968f54752d21fx1280x2237.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Phases of HMP Shunt and the Enzymes Involved</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phases</strong></p>\n</td>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Irreversible oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Glucose-6-phosphate dehydrogenase</p>\n<p>6-Phosphogluconate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reversible non-oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>3-Epimerase or Keto-isomerase</p>\n<p>Transketolase</p>\n<p>Transaldolase</p>\n<p>Phosphohexose isomerase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Rate determining enzymes and their key regulators</h3><table>\n<tbody>\n<tr>\n<td>Pathway</td>\n<td>Enzyme&nbsp;</td>\n<td>Regulating factors</td>\n</tr>\n<tr>\n<td>Glycolysis</td>\n<td>Phosphofructokinase (PFK-1)</td>\n<td>\n<p>AMP+, Fructose 2,6 bi-phosphate+</p>\n<p>ATP-, Citrate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;gluconeogenesis</td>\n<td>Fructose-1,6-bisphosphatase</td>\n<td>\n<p>ATP+, Acetyl CoA+</p>\n<p>AMP-, Fructose 2,6 bi-phosphate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Krebs cycle</td>\n<td>Isocitrate dehydrogenase</td>\n<td>\n<p>ADP+,</p>\n<p>ATP-, NADH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenesis</td>\n<td>Glycogen synthase</td>\n<td>\n<p>Glucose-6-phosphate+, insulin+, cortisol+,</p>\n<p>Epinephrine-, glucagon-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenolysis</td>\n<td>Glycogen phosphorylase</td>\n<td>\n<p>Epinephrine+, glucagon+, AMP+</p>\n<p>Glucose-6-phosphate-, insulin-, ATP-</p>\n</td>\n</tr>\n<tr>\n<td>HMP shunt&nbsp;</td>\n<td>Glucose-6-phosphate dehydrogenase (G6PD)</td>\n<td>\n<p>NADP+</p>\n<p>NADPH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo pyrimidine synthesis</td>\n<td>Carbamoyl phosphate synthetase II</td>\n<td>\n<p>ATP+</p>\n<p>UTP-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo purine synthesis</td>\n<td>Glutamine-phosphoribosylpyrophosphate (PRPP) amidotransferase</td>\n<td>AMP-, IMP-, GMP-</td>\n</tr>\n<tr>\n<td>&nbsp;Urea cycle</td>\n<td>Carbamoyl phosphate synthetase I</td>\n<td>N-acetyl glutamate (NAG)+</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid synthesis</td>\n<td>Acetyl-CoA carboxylase (ACC)</td>\n<td>\n<p>Insulin+, citrate+</p>\n<p>Glucagon-, palmitoyl-CoA-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid oxidation</td>\n<td>Carnitine acyltransferase I</td>\n<td>Malonyl-CoA-</td>\n</tr>\n<tr>\n<td>&nbsp;Cholesterol synthesis</td>\n<td>HMG-CoA reductase</td>\n<td>\n<p>Insulin+, thyroxine+</p>\n<p>Glucagon-, cholesterol-</p>\n</td>\n</tr>\n<tr>\n<td>Ketogenesis</td>\n<td>HMG-CoA synthase</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>+ Positive effect on the pathway.</p>\n<p>- Negative effect on the pathway.</p><hr><h3>Related Pearl: Reducing Equivalents and Their Uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Reducing agents</p>\n</td>\n<td>\n<p>Uses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADPH</p>\n</td>\n<td>\n<p>Lipid synthesis</p>\n<p>Cholesterol synthesis&nbsp;</p>\n<p>Fatty acid chain elongation</p>\n<p>Cytochrome P450&nbsp;hydroxylation&nbsp;of&nbsp;aromatic compounds, steroids,&nbsp;alcohols, and&nbsp;drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADH</p>\n</td>\n<td>\n<p>Metabolizes alcohol</p>\n<p>Glycolysis &amp; Krebs cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>&beta;- Oxidation of fatty acid</p>\n<p>Catalyzes reactions in muscle and liver cells</p>\n<p>Electron Transport Chain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FADH<sub>2</sub></p>\n</td>\n<td>\n<p>Krebs cycle</p>\n<p>Electron Transport Chain</p>\n<p>Oxidative Phosphorylation</p>\n<p>Cytochrome P450 hydroxylase cycle</p>\n<p>&beta;-Oxidation of fatty acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7234",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following enzymes use selenocysteine?<div class='question-desc-html'><p>1. Glutathione peroxidase<br />2. Glutathione&nbsp;synthase<br />3. Deiodinase<br />4. Thioredoxin reductase&nbsp; &nbsp; &nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 3"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The enzymes that use selenocysteine are&nbsp;<strong>glutathione peroxidase</strong>, <strong>deiodinase</strong>, and<strong>&nbsp;thioredoxin reductase</strong>.&nbsp;</p>\n<p><strong>Selenocysteine </strong>is<strong>&nbsp;</strong>the<strong> 21<sup>st</sup> amino acid</strong> coded by the <strong>UGA codon</strong>, which is normally a <strong>stop codon.&nbsp;</strong>It is formed by <strong>co-translational modification</strong>.<strong>&nbsp;</strong>The protein synthetic apparatus can identify a selenocysteine-encoding UGA by the presence of the selenocysteine insertion sequence (SECIS) in the untranslated region of mRNA.</p>\n<p>Enzymes such as thioredoxin reductase, glutathione peroxidase,&nbsp;and deiodinase use selenocysteine to <strong>catalyze redox reactions</strong>. Defects in human selenoproteins are associated with tumorigenesis and atherosclerosis. It can cause&nbsp;<strong>cardiomyopathy </strong>due to<strong> selenium deficiency,&nbsp;</strong>which is&nbsp;known as<strong> Keshan disease</strong>.</p>\n<p><strong>Glutathione synthase</strong> is the second enzyme in the <strong>synthesis</strong> of glutathione. Glutathione plays an important role in&nbsp;oxidative stress,&nbsp;redox signalling, and regulates cell proliferation and apoptosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3942",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with reduced levels of high-density lipoprotein, and ABCA1 mutation. On examination, tonsils appeared as shown in the image. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Tangier's disease"
        },
        {
          "id": 2,
          "text": "Abetalipoprotenemia"
        },
        {
          "id": 3,
          "text": "Hyperlipoproteinemia"
        },
        {
          "id": 4,
          "text": "Wolman's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The diagnosis in this case with&nbsp;reduced levels of high-density lipoprotein (HDL),&nbsp;ABCA1 mutation, and&nbsp;<strong>orange tonsils </strong>on examination is&nbsp;<strong>Tangier's disease.</strong>&nbsp;It is caused by a defect in ABCA1 receptors.</p>\n<p>ABCA1 plays a role in the <strong>efflux of cholesterol</strong> from <strong>peripheral cells</strong> of<strong> HDL</strong>. LCAT (lecithin cholesterol acyltransferase) converts cholesterol to cholesterol esters, which accumulate in the core of HDL. Thus, defective ABCA1 will lead to low levels of HDL in the blood.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Abetalipoproteinemia</strong> is a hypolipoproteinemia caused by a defect in the MTP gene. Here, loading apolipoprotein B with lipids is defective. Hence, few very low density-lipoproteins (VLDLs) or chylomicrons are formed, leading to the accumulation of&nbsp;<strong>triacylglycerols</strong>&nbsp;in the liver and intestine.</p>\n<p>Option C:&nbsp;<strong>Hyperlipoproteinemia</strong> is a disorder that causes the body to metabolize lipids incorrectly. This results in hyperlipidemia and can lead to the development of multiple small xanthomas in the skin.</p>\n<p>Option D:<strong>&nbsp;Acid lipase&nbsp;</strong>deficiency can lead to&nbsp;<strong>Wolman's disease</strong>&nbsp;which is a lysosomal storage disease. The pathognomic feature of this condition is&nbsp;<strong>adrenal calcification</strong>. So patients generally present with adrenal insufficiency and are neonates.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5e11351831634fb996e3e160d75a2a06.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7227",
      "difficulty": "easy"
    },
    {
      "text": "A baby is being evaluated for delayed developmental milestones. On examination, the child has hepatosplenomegaly. A microscopic image of the bone marrow evaluation is shown below. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Gaucher disease"
        },
        {
          "id": 2,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 3,
          "text": "Hunter disease"
        },
        {
          "id": 4,
          "text": "Hurler disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The microscopic image of the bone marrow biopsy shows <strong>Gaucher cells</strong> and the diagnosis is <strong>Gaucher disease</strong>.</p>\n<p>Gaucher disease is a&nbsp;<strong>lysosomal storage disease</strong>&nbsp;with&nbsp;<strong>autosomal recessive</strong>&nbsp;inheritance.&nbsp;The condition results due to the deficiency of <strong>acid &beta;-glucosidase</strong>. This results in the accumulation of glucosylceramide (a glycolipid substrate) in the reticuloendothelial cells. There is progressive infiltration of the<strong> liver, spleen</strong>, and bone marrow.&nbsp;</p>\n<p>There are three clinical types:</p>\n<ul>\n<li>Type 1:&nbsp;<strong>Adult</strong>&nbsp;(non-neuronopathic form)</li>\n<li>Type 2:&nbsp;<strong>Infantile</strong>&nbsp;(acute neuronopathic form)</li>\n<li>Type 3:&nbsp;<strong>Juvenile</strong>&nbsp;(subacute neuronopathic form)</li>\n</ul>\n<p>Type 1 is the most common. It presents with a myriad of symptoms, such as bruising secondary to&nbsp;<strong>thrombocytopenia</strong>, fatigue due to&nbsp;<strong>anemia</strong>, <strong>hepatosplenomegaly,</strong> and&nbsp;<strong>bone pain</strong>. Lytic lesions and osteosclerosis of the femur, ribs, and pelvis may also be seen. A few patients may have pulmonary involvement. Growth retardation may be observed in cases presenting in the first decade.&nbsp;</p>\n<p>Type 2 is rare, and presents with&nbsp;<strong>hypertonia,</strong>&nbsp;strabismus, and organomegaly. <strong>Neurodegeneration</strong> is the characteristic feature.&nbsp;<strong>Stridor</strong>&nbsp;and failure to thrive can also be the presenting features. Ultimately, death can occur due to respiratory arrest.&nbsp;</p>\n<p>Type 3 presents with intermediate symptoms, as seen in the other two types. By the age of 10-15 years, the child succumbs to death.</p>\n<p><strong>Gaucher&nbsp;cells&nbsp;</strong>&nbsp;are <strong>reticuloendothelial cells</strong> with glucosylceramide, and have a&nbsp;<strong>wrinkled-paper appearance</strong>&nbsp;due to <strong>intracytoplasmic</strong> substrate inclusions. These cells stain strongly with&nbsp;<strong>periodic acid-Schiff</strong>&nbsp;(PAS) stain. This is characteristic of Gaucher's disease.</p>\n<p>Other options:</p>\n<p>Option B -&nbsp;<strong>Acid sphingomyelinase</strong>&nbsp;deficiency results in&nbsp;<strong>Niemann-Pick disease types A</strong>&nbsp;and&nbsp;<strong>B</strong>. Both are&nbsp;<strong>autosomal recessive</strong>&nbsp;conditions. Type A has a neurodegenerative course, while type B is non-neuronopathic. The former presents with hepatosplenomegaly, lymphadenopathy, and psychomotor retardation. Type B is associated with hepatosplenomegaly and mild pulmonary involvement.&nbsp;</p>\n<p>Option-C - <strong>Hunter disease</strong> is an X-linked inherited disorder due to a deficiency of the enzyme<strong> iduronate sulfatase</strong>. It leads to the accumulation of dermatan and heparan sulfate. Clinical features involve coarse facies, cardiovascular involvement, and distinctive skin lesions.</p>\n<p>Option-D - <strong>Hurler/Scheie disease</strong> is a mucopolysaccharidosis that has childhood and adult onset. It presents with <strong>cognitive degeneration</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/deb7bda443454a1f8c6873f61053fb78.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8213",
      "difficulty": "easy"
    },
    {
      "text": "Refsum disease is due to:",
      "choices": [
        {
          "id": 1,
          "text": "Absence of alpha oxidation in peroxisomes"
        },
        {
          "id": 2,
          "text": "Absence of beta oxidation in peroxisomes"
        },
        {
          "id": 3,
          "text": "Absence of alpha oxidation in lysosomes"
        },
        {
          "id": 4,
          "text": "Absence of beta oxidation in lysosomes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Refsum disease is due to the <strong>absence</strong> of <strong>alpha oxidation</strong> in <strong>peroxisomes</strong>.</p>\n<p>Refsum's disease is a rare <strong>autosomal recessive</strong> disorder. The defective enzyme is&nbsp;<strong>phytanoyl CoA hydroxylase, </strong>which causes&nbsp;alpha oxidation&nbsp;of fatty acids and leads to&nbsp;<strong>elevated levels</strong>&nbsp;of<strong>&nbsp;phytanic acid</strong>&nbsp;in the blood.</p>\n<p>Clinical features are dysmorphic facies and&nbsp;<strong>severe neurological symptoms&nbsp;</strong>such as&nbsp;polyneuropathy, <strong>retinitis pigmentosa</strong>, nerve deafness, <strong>ichthyosis</strong>, and cerebellar ataxia.</p>\n<p><strong>Restricted dietary intake</strong>&nbsp;of phytanic acid reduces the symptoms. Management includes avoiding sources of phytanic acid such as dairy products, meat, nuts, and green leafy vegetables.</p><hr><h3>Related Pearl: Types, Location and Properties of Fatty acid oxidation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the &alpha;(2) and&nbsp;&beta;(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and &alpha;(2) carbon removing that carbon as CO2. The remaining chain is activated with CoA and then undergoes&nbsp;&beta;-Oxidation.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsum's Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\"p2\">&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the &omega; carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary &beta;-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further &beta;-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\"p2\">They accumulate C<span class=\"s1\">26</span>&mdash;C<span class=\"s1\">38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5775",
      "difficulty": "medium"
    },
    {
      "text": "Choose the right sequence of steps in the conversion of cholesterol to testosterone.<div class='question-desc-html'><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">a. 17 alpha-hydroxylase<br />b. 20, 22 desmolase<br />c. 17, 20 lyase<br />d. 3 beta hydroxy steroid dehydrogenase<br /></span></p></div>",
      "choices": [
        {
          "id": 1,
          "text": "b, d, a, c"
        },
        {
          "id": 2,
          "text": "a, c, d, b"
        },
        {
          "id": 3,
          "text": "b, a, c, d"
        },
        {
          "id": 4,
          "text": "d, a, b. c"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct sequence of steps in the conversion of cholesterol to testosterone is:</p>\n<p>b.&nbsp;<span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">20, 22 desmolase<br /></span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">d.&nbsp;</span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">3 b</span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">eta-hydroxy steroid dehydrogenase<br /></span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">a. 17 alpha-hydroxylase<br /></span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">c.&nbsp;</span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Choose the right sequence of steps in the conversion of cholesterol to testosterone\\na. 17 alpha hydroxylase\\nb. 20, 22 desmolase\\nc. 17, 20 desmolase\\nd. 3 beta hydroxy steroid dehydrogenase\\n&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:963,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16776960},&quot;9&quot;:0,&quot;10&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0}\">17, 20 lyase</span></p>\n<p>The step of synthesis of sex steroids is illustrated in the diagram below.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/06b835f663d042b582fe7e0d8e062422x1280x2002.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Variants of Congenital Adrenal Hyperplasia (CAH)</h3><table>\n<tbody>\n<tr>\n<td><strong>21-hydroxylase deficiency</strong></td>\n<td><strong>17-hydroxylase deficiency</strong></td>\n<td><strong>11&beta;-hydroxylase deficiency</strong></td>\n<td><strong>3&beta;-HSD deficiency</strong></td>\n</tr>\n<tr>\n<td>\n<p>Deficiency of cortisol and aldosterone</p>\n</td>\n<td>\n<p>Deficiency of cortisol and sex hormones</p>\n</td>\n<td>\n<p>Deficiency of cortisol</p>\n</td>\n<td>\n<p>Deficiency of cortisol, aldosterone, and testosterone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&uarr; in testosterone</p>\n</td>\n<td>&uarr; in aldosterone</td>\n<td>&uarr; in deoxycorticosterone (mineralocorticoid) and testosterone&nbsp;</td>\n<td>&uarr; in DHEA</td>\n</tr>\n<tr>\n<td>Salt wasting crises</td>\n<td>Salt retention and&nbsp; hypertension</td>\n<td>\n<p>Salt retention and&nbsp; hypertension</p>\n</td>\n<td>Salt-wasting crises</td>\n</tr>\n<tr>\n<td>Virilization of females (ambiguous genitalia 46XX) &nbsp;&nbsp;&nbsp;</td>\n<td>Failure of sexual development in females at puberty</td>\n<td>Virilization of females&nbsp; (ambiguous genitalia 46XX)</td>\n<td>Females are mildly<br /> virilized (DHEA is a weak androgen)</td>\n</tr>\n<tr>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note</strong>: In&nbsp;11&beta;-hydroxylase deficiency, aldosterone synthetic capacity is normal and some corticosterone is synthesized from progesterone by intact aldosterone synthase enzyme. Thus, it is unusual for patients to manifest signs of adrenal insufficiency.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7232",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following describes the relationship between the melting temperature (Tm) of DNA and the concentration of G-C and A-T?",
      "choices": [
        {
          "id": 1,
          "text": "No relation of GC with Tm"
        },
        {
          "id": 2,
          "text": "Tm increases with more A-T"
        },
        {
          "id": 3,
          "text": "Tm decreases with more G-C"
        },
        {
          "id": 4,
          "text": "Tm increases with more G-C"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correct statement about the <strong>melting temperature of DNA&nbsp;(Tm)</strong> is that it i<strong>ncreases with more G-C concentration.</strong></p>\n<p>On heating the DNA, the temperature at which one-half of the helical structure loses its structure defines the melting temperature Tm.&nbsp;The two strands of the double helix structure of the DNA get separated when the <strong>hydrogen bonds</strong> between the base pairs are disrupted. Thus, the Tm is influenced by the concentrationbase composition of the DNA.</p>\n<p>Since <strong>G-C</strong> pairing has <strong>3 hydrogen bonds</strong> and <strong>A-T</strong> pairing has <strong>2 hydrogen bonds</strong>,<strong>&nbsp;</strong>DNA rich in G-C base pairs requires higher temperatures to denature in comparison to DNA rich in A-T base pairs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7415",
      "difficulty": "medium"
    },
    {
      "text": "An elderly patient on a vegetarian diet presenting with easy fatigability and pallor was investigated. Peripheral smear showed findings of macrocytic anemia. What is the probable cause of anemia in this patient? Other lab findings are as follows:<div class='question-desc-html'><p>Hemoglobin - 9 g/dL</p>\n<p>Mean corpuscular volume (MCV) - 112 fL</p>\n<p>Serum homocysteine - Elevated</p>\n<p>Serum methylmalonic acid - Normal</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Folate deficiency"
        },
        {
          "id": 2,
          "text": "Alcohol-induced macrocytosis"
        },
        {
          "id": 3,
          "text": "Vitamin B12 deficiency"
        },
        {
          "id": 4,
          "text": "Thiamine deficiency"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The probable cause of anemia in this patient of <strong>folate</strong> <strong>deficiency</strong>.</p>\n<p>The given clinical scenario of <strong>macrocytic anemia</strong> in a <strong>vegetarian</strong> with <strong>elevated homocysteine</strong> levels is due to <strong>megaloblastic anemia</strong>, which can be caused by the deficiency of vitamin B<sub>12</sub> or folic acid. Vitamin B<sub>12</sub> deficiency is associated with raised serum methylmalonic acid (MMA) levels, which are normal in this patient; hence, folic acid deficiency is the cause of megaloblastic anemia in this patient.</p>\n<p>Folic acid deficiency is associated with the following clinical and laboratory findings:</p>\n<ul>\n<li><strong>Raised MCV</strong> (normal range: 80&ndash;100 fL)&nbsp;- <strong>macrocytosis</strong></li>\n<li>Normal MCHC (normal range: 33&ndash;36 g/dL)&nbsp;</li>\n<li>Increased MCH</li>\n<li>Elevated RDW</li>\n<li>Decreased reticulocyte count -&nbsp;due to destruction of abnormal erythroid precursors</li>\n<li><strong>Elevated homocysteine level</strong></li>\n<li><strong>Normal MMA level</strong></li>\n</ul>\n<p>where MCV<strong>,&nbsp;</strong>mean corpuscular volume;&nbsp;MCHC, mean corpuscular hemoglobin concentration; mean corpuscular hemoglobin, MCH; RDW, red cell distribution width</p>\n<p>In vitamin <strong>B12</strong> deficiency, neurological abnormalities,&nbsp;<strong>elevated homocysteine,</strong> and <strong>elevated MMA</strong> levels are seen.&nbsp;</p><hr><h3>Related Pearl: Morphological Classification of Anemias</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microcytic Hypochromic </strong></p>\n<p><strong>(MCV &lt;80 fl)</strong></p>\n</td>\n<td>\n<p><strong>Normocytic Normochromic    </strong></p>\n<p><strong>(MCV 80 - 100 fl)</strong></p>\n</td>\n<td>\n<p><strong>Macrocytic Normochromic </strong></p>\n<p><strong>(MCV &gt;100 fl)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron deficiency anemia</p>\n<p>Sideroblastic anemia</p>\n<p>Thalassemia</p>\n<p>Lead toxicity</p>\n</td>\n<td>\n<p>Acute blood loss</p>\n<p>Anemia of chronic disease</p>\n<p>Anemia of renal disease</p>\n<p>Hemolysis*</p>\n<p>Bone marrow suppression</p>\n<ul>\n<li>Aplastic anemia</li>\n<li>Pure red cell aplasia</li>\n</ul>\n<p> </p>\n<p>  </p>\n</td>\n<td>\n<p><strong>Megaloblastic:</strong></p>\n<p>Vitamin B12 deficiency</p>\n<p>Folate deficiency</p>\n<p>Thiamine deficiency</p>\n<p>Drugs - Methotrexate, Zidovudine, hydroxyurea</p>\n<p>Orotic aciduria</p>\n<p> </p>\n<p><strong>Non-megaloblastic:</strong></p>\n<p>Alcohol use</p>\n<p>Liver disease</p>\n<p>Hypothyroidism</p>\n<p>Hemolysis*</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Hemolysis can be associated with macrocytosis because of compensatory reticulocytosis. However, MCV can be normal depending on the degree of hemolysis.</p>\n<p>Note: In Orotic Aciduria, peripheral blood smear shows Hypochromic megaloblastic anemia. </p><hr><h3>Related Pearl: Difference between B12 and Folic acid Deficiency</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Laboratory Tests</strong></p>\n</td>\n<td>\n<p><strong>Pernicious Anemia (B12 Deficiency)</strong></p>\n</td>\n<td>\n<p><strong>Folic Acid Deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum B12 level</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum folic acid level</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum LDH level</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Achlorhydria</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Schilling Test</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Methyl malonyl CoA in urine</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurological signs</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7407",
      "difficulty": "medium"
    },
    {
      "text": "Zellweger syndrome is due to a defect in the biogenesis of:",
      "choices": [
        {
          "id": 1,
          "text": "Peroxisomes"
        },
        {
          "id": 2,
          "text": "Lysosomes"
        },
        {
          "id": 3,
          "text": "Mitochondria"
        },
        {
          "id": 4,
          "text": "Nucleus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Zellweger syndrome is due to a defect in the biogenesis of <strong>peroxisomes</strong>.</p>\n<p>Zellweger syndrome is&nbsp;also known&nbsp;as&nbsp;<strong>cerebrohepatorenal syndrome.&nbsp;</strong>It is caused by <strong>mutations</strong> in the&nbsp;<strong>PEX</strong>&nbsp;family of genes. This results in <strong>defective beta-oxidation </strong>of&nbsp;<strong>very long-chain fatty acids.</strong></p>\n<p>The child presents with</p>\n<ul>\n<li>Dysmorphic facial features.&nbsp;</li>\n<li>Weakness, hypotonia.</li>\n<li>Neonatal seizures</li>\n<li>Eye abnormalities.</li>\n</ul>\n<p>Biochemical findings will show<strong>&nbsp;</strong>:</p>\n<ul>\n<li>Accumulation of&nbsp;<strong>very-long-chain fatty acids, phytanic acid</strong></li>\n<li>Abnormalities in the synthesis of bile acids</li>\n<li>Marked <strong>reduction </strong>of <strong>plasmalogens</strong></li>\n</ul>\n<p>There is <strong>no appropriate treatment</strong> for Zellweger syndrome. It is very severe and infants rarely survive beyond a few months.</p><hr><h3>Related Pearl: Types, Location and Properties of Fatty acid oxidation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the &alpha;(2) and&nbsp;&beta;(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and &alpha;(2) carbon removing that carbon as CO2. The remaining chain is activated with CoA and then undergoes&nbsp;&beta;-Oxidation.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsum's Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\"p2\">&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the &omega; carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary &beta;-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further &beta;-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\"p2\">They accumulate C<span class=\"s1\">26</span>&mdash;C<span class=\"s1\">38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7385",
      "difficulty": "easy"
    },
    {
      "text": "True statement about the action of enhancers of gene expression?",
      "choices": [
        {
          "id": 1,
          "text": "Work only when in close conjugation with promoter region"
        },
        {
          "id": 2,
          "text": "Work only when in upstream of promoter region"
        },
        {
          "id": 3,
          "text": "They are very specific to the gene"
        },
        {
          "id": 4,
          "text": "Recruit chromatin and modify regulatory mechanisms"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correct statement about the action of <strong>enhancers</strong> is that they <strong>recruit chromatin and modify regulatory mechanisms.</strong></p>\n<p>A <strong>promoter</strong><span> is a sequence on DNA where <strong>RNA polymerase binds</strong> and acts as the start signal for transcription. They are present upstream or downstream but close to the gene that is undergoing transcription. </span></p>\n<p><span><strong>Enhancers </strong>or <strong>repressors</strong> are proteins that regulate the expression of a gene by <strong>recruiting chromatin</strong>(DNA bound with histones) and <strong>modifying regulatory mechanisms</strong> and making it more or less <strong>accessible to transcription</strong> by RNA polymerase. They may be <strong>located upstream </strong>or</span><strong> downstream</strong> and can be present at <strong>any distance</strong> from the promoter region. These are <strong>not specific to any single gene</strong> and interact with many other proteins.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7401",
      "difficulty": "hard"
    },
    {
      "text": "Increased H+ ions in the intermembrane space of mitochondria are due to?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased oxidative phosphorylation"
        },
        {
          "id": 2,
          "text": "Increased ATP production"
        },
        {
          "id": 3,
          "text": "Reduced chemiosmosis"
        },
        {
          "id": 4,
          "text": "Water retention in inner mitochondrial space"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Increased H+ ions in the intermembrane space of mitochondria are due to <strong>decreased oxidative phosphorylation.</strong></p>\n<p>ATP is synthesized in mitochondria by a process called oxidative phosphorylation. The oxidation of substrates like carbohydrates, amino acids, or fats produces reducing equivalents (NADH, FADH2). These equivalents enter the electron transport chain and transfer a proton (H+) to the inter-membrane space. The inner mitochondrial membrane is not permeable to protons leading to the accumulation of H+ in the intermembrane space. The flow<span>&nbsp;of these protons through the Fo releases the energy that phosphorylates ADP to form ATP.</span></p>\n<p>Drugs that inhibit oxidative phosphorylation like <strong>oligomycin</strong> <strong>inhibit </strong>the<strong> flow of protons through Fo</strong> causing an<strong> increase </strong>in <strong>H+ ions </strong>in the<strong> intermembrane space.</strong></p><hr><h3>Related Pearl: Inhibitors of metabolic pathways</h3><p><strong>Inhibitors of glycolysis</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Iodoacetate</td>\n<td>Glyceraldehyde 3-phosphate dehydrogenase</td>\n</tr>\n<tr>\n<td>Arsenate</td>\n<td>Phosphoglycerate kinase</td>\n</tr>\n<tr>\n<td>Fluoride</td>\n<td>Enolase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of TCA cycle</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Fluoroacetate</td>\n<td>Aconitase</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 176\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Arsenite</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&alpha;-ketoglutarate dehydrogenase</td>\n</tr>\n<tr>\n<td>Malonate</td>\n<td>Succinate dehydrogenase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of electron transport</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complex</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>Complex I</td>\n<td>Piercidin, Amobarbital, Rotenone</td>\n</tr>\n<tr>\n<td>Complex II</td>\n<td>TTFA, Carboxin, Malonate</td>\n</tr>\n<tr>\n<td>Complex III</td>\n<td>BAL, Antimycin A</td>\n</tr>\n<tr>\n<td>Complex IV</td>\n<td>Hydrogen sulphide, Carbon monoxide, Cyanide</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of oxidative phosphorylation</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Atractyloside</td>\n<td>Inhibits ADP and ATP Transporter</td>\n</tr>\n<tr>\n<td>Oligomycin</td>\n<td>Blocks flow of protons through Fo complex</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7398",
      "difficulty": "medium"
    },
    {
      "text": "Fructosamine is obtained by glycation of:",
      "choices": [
        {
          "id": 1,
          "text": "Frustose"
        },
        {
          "id": 2,
          "text": "Albumin"
        },
        {
          "id": 3,
          "text": "Urea"
        },
        {
          "id": 4,
          "text": "Glycosaminoglycans"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Fructosamine is obtained by the glycation of <strong>albumin</strong>.</p>\n<p>Fructosamine is a measure of <strong>non-enzymatic</strong> glycation of circulating proteins including <strong>albumin</strong>, globulins, and lipoproteins. It is now used as a&nbsp; reasonable <strong>alternative</strong> to <strong>HbA1c measurement</strong> when it is not reliable. Since albumin is the <strong>most abundant</strong> of the serum proteins, fructosamine is predominantly a measure of glycated albumin.</p>\n<p>Fructosamine is used as a <strong>short-term</strong> marker of glucose control. It&nbsp;reflects the average glycemia over the preceding<strong>&nbsp;2 to 3 weeks</strong>. HbA1c reflects glucose control over a period of the preceding 8 to 12 weeks.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7386",
      "difficulty": "hard"
    }
  ]
}